Literature DB >> 31422939

Ubiquitination and SUMOylation in HIV Infection: Friends and Foes.

Marta Colomer-Lluch1, Sergio Castro-Gonzalez2, Ruth Serra-Moreno2.   

Abstract

As intracellular parasites, viruses hijack the cellular machinery to facilitate their replication and spread. This includes favouring the expression of their viral genes over host genes, appropriation of cellular molecules, and manipulation of signalling pathways, including the post-translational machinery. HIV, the causative agent of AIDS, is notorious for using post-translational modifications to generate infectious particles. Here, we discuss the mechanisms by which HIV usurps the ubiquitin and SUMO pathways to modify both viral and host factors to achieve a productive infection, and also how the host innate sensing system uses these post-translational modifications to hinder HIV replication.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31422939      PMCID: PMC6987006          DOI: 10.21775/cimb.035.159

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  237 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization.

Authors:  Edward M Campbell; Jared Weingart; Paola Sette; Silvana Opp; Jaya Sastri; Sarah K O'Connor; Sarah Talley; Felipe Diaz-Griffero; Vanessa Hirsch; Fadila Bouamr
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

3.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.

Authors:  Xiaolu Wu; Jenny L Anderson; Edward M Campbell; Ajith M Joseph; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

4.  Host protein Ku70 binds and protects HIV-1 integrase from proteasomal degradation and is required for HIV replication.

Authors:  Yingfeng Zheng; Zhujun Ao; Binchen Wang; Kallesh Danappa Jayappa; Xiaojian Yao
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

5.  Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor.

Authors:  Rittik Chaudhuri; O Wolf Lindwasser; William J Smith; James H Hurley; Juan S Bonifacino
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

6.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

7.  Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology.

Authors:  Sabine Kupzig; Viktor Korolchuk; Ruth Rollason; Anna Sugden; Andrew Wilde; George Banting
Journal:  Traffic       Date:  2003-10       Impact factor: 6.215

8.  Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5α.

Authors:  Alberto Brandariz-Nuñez; Amanda Roa; Jose Carlos Valle-Casuso; Nikolaos Biris; Dmitri Ivanov; Felipe Diaz-Griffero
Journal:  Virology       Date:  2012-10-16       Impact factor: 3.616

9.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.

Authors:  O Schwartz; V Maréchal; S Le Gall; F Lemonnier; J M Heard
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  TRIM5α is a SUMO substrate.

Authors:  Jacques Dutrieux; Débora M Portilho; Nathalie J Arhel; Uriel Hazan; Sébastien Nisole
Journal:  Retrovirology       Date:  2015-03-24       Impact factor: 4.602

View more
  5 in total

Review 1.  Regulation of Viral Restriction by Post-Translational Modifications.

Authors:  Célia Chamontin; Guillaume Bossis; Sébastien Nisole; Nathalie J Arhel; Ghizlane Maarifi
Journal:  Viruses       Date:  2021-11-01       Impact factor: 5.048

2.  First report of computational protein-ligand docking to evaluate susceptibility to HIV integrase inhibitors in HIV-infected Iranian patients.

Authors:  Farzane Ghasabi; Ava Hashempour; Nastaran Khodadad; Soudabeh Bemani; Parisa Keshani; Mohamad Javad Shekiba; Zahra Hasanshahi
Journal:  Biochem Biophys Rep       Date:  2022-03-29

3.  Human immunodeficiency virus type 1 impairs sumoylation.

Authors:  Bilgül Mete; Emre Pekbilir; Bilge Nur Bilge; Panagiota Georgiadou; Elif Çelik; Tolga Sutlu; Fehmi Tabak; Umut Sahin
Journal:  Life Sci Alliance       Date:  2022-02-18

4.  Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function.

Authors:  Ashley M Campbell; Carlos F De La Cruz-Herrera; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  PLoS Pathog       Date:  2022-01-10       Impact factor: 6.823

5.  HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride co-transporter in the distal convoluted tubule.

Authors:  Shashi Shrivastav; Hewang Lee; Koji Okamoto; Huiyan Lu; Teruhiko Yoshida; Khun Zaw Latt; Hidefumi Wakashin; James L T Dalgleish; Erik H Koritzinsky; Peng Xu; Laureano D Asico; Joon-Yong Chung; Stephen Hewitt; John J Gildea; Robin A Felder; Pedro A Jose; Avi Z Rosenberg; Mark A Knepper; Tomoshige Kino; Jeffrey B Kopp
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.